Journal profile

JMIRx Med

ISSN 2563-6316 · JMIR Publications · Canada

JMIRx Med: fully open access; APC about USD 1,000; median 279 days to acceptance (43 articles, last 24 months); 150 articles in 2025.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartile—No CiteScore rank
Review time279 daysMedian, submission to acceptance · 43 articles, last 24 months · PubMed
APCUSD 1,000Fully open access
Acceptance—No reports yet
Articles per year1502025 · OpenAlex count

Scope

Aims, scope and focus

JMIRx Med is published by JMIR Publications. By OpenAlex counts of its recent articles, its largest topics are COVID-19 epidemiological studies, COVID-19 Clinical Research Studies and SARS-CoV-2 and COVID-19 Research, together about 27.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

JMIRx Med (ISSN 2563-6316), which has been accepted for indexing in PubMed and PubMed Central, is an innovative overlay journal to MedRxiv and JMIR Preprints (other preprint servers are invited to join). JMIRx peer-reviews preprints and publishes their revised "version of record" with peer-review reports across a broad range of medical, clinical and related health sciences. Unlike the majority of JMIR journals, papers published in this journal do not require a digital health focus - in fact, most papers we published in the first months of the journal were related to COVID19, but we publish all research that qualifies for preprinting on MedRxiv. Conceived to address the urgent need to make highly relevant scientific information available as early as possible without losing the quality of the peer-reviewed process, this innovative new journal is the first in a new series of “superjournals”. Superjournals (a type of "overlay" journal) sit on top of preprint servers (JMIRx-Med serves MedRxiv and JMIR Preprints), offering peer-review and everything else a traditional scholarly journal does. Our goal is to rapidly peer review and publish a paper. All JMIRx Med papers must have originated as a preprint. All JMIRx Med papers are rigorously peer-reviewed, copyedited and XML-tagged. Accepted papers are published along with the related Peer Review Reports and Author Responses to Peer Review Reports, providing an additional layer of transparency to the scholarly publishing process. To submit a preprint to JMIRx, either submit a Preprint directly to JMIRx (and opt-in when you are asked to expose the submission on JMIR Preprints) or upload a Preprint to MedRxiv and then user the M2J (or here called M2JMIR) functionality at MedRxiv to submit the paper to the Journal of Medical Internet Research - you will then receive an email with a link to the JMIR submission form, where you must change the target journal to JMIRx. For more information please consult our Knowledge Base article "What is JMIRx?" Need help choosing a journal? Use our Journal Finder tool to find the perfect match for your manuscript. Get Started

From the journal's Aims & Scope

Editor-in-chief Fuqing WuPublisher website

Editorial board by country: none in mainland China; most named United States 5, Taiwan, China 1, Thailand 1 (7 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. COVID-19 epidemiological studiesMathematics11.2%
  2. COVID-19 Clinical Research StudiesMedicine8.3%
  3. SARS-CoV-2 and COVID-19 ResearchMedicine7.9%
  4. Artificial Intelligence in Healthcare and EducationMedicine7.4%
  5. Artificial Intelligence in HealthcareHealth Professions6.6%
  6. Mobile Health and mHealth ApplicationsHealth Professions6%
  7. Data-Driven Disease SurveillanceMedicine6%
  8. Machine Learning in HealthcareComputer Science5.6%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

DOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

PMCPubMedPublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

h-index
22OpenAlex ·
i10-index
66OpenAlex ·
2-year mean citedness
3.24OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 623 in total · the current year is incomplete

YearArticlesOpen accessCitations
20264040338
2025150150498
2024106106368
20232424293
2022115115472
2021173173428

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

279 daysMedian, submission to acceptance · P25–P75 178 days – 456 days

Acceptance to online
median 58 days (43 articles)
Submission to online
median 332 days
Sample
43 articles with submission and acceptance dates (51 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 16 weeksLetPub ·
Submission to publication (journal-reported)
about 35 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 1,000YesCC BY
OpenAlexUSD 1,000——
LetPubUSD 1,000Yes—
Publisher websiteYes, amount not published——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare1 items from the author guidelines
Cover letter
Required
Publisher website · model-extracted, each line checked against the text
Policy excerpts from the journal's websitePeer review, Preprints
Peer review Preprints Open for Peer Review

There are no preprints available for open peer-review at this time. Please check back later.

Source ↗Publisher website ·
Preprints PubMed-indexed overlay journal for preprints with post-review manuscript marketplace (What is JMIRx?).

Editor-in-Chief: Fuqing Wu, PhD, The University of Texas Health Science Center at Houston, School of Public Health, Texas, USA JMIRx Med (ISSN 2563-6316), which has been accepted for indexing in PubMed and PubMed Central, is an innovative overlay journal to MedRxiv and JMIR Preprints (other preprint servers are invited to join). JMIRx peer-reviews preprints and publishes their revised "version of …

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
JMIR Publications
Country or region
Canada
Language
English
ISSN
2563-6316
Official links

FAQ

Frequently asked questions about JMIRx Med

How long does peer review take at JMIRx Med?

Based on the dates recorded on 43 articles published between November 2024 and November 2026 (the last 24 months), the median time from submission to acceptance is 279 days (interquartile range 178–456 days); authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of JMIRx Med based?

Of the 7 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (5), Taiwan, China (1) and Thailand (1). Counted from the institutions listed on the board page; for reference only.

Which databases index JMIRx Med?

According to LetPub and DOAJ records, JMIRx Med is indexed in DOAJ. The journal's website also lists PMC and PubMed; that list has not been checked against each database.

Is JMIRx Med open access, and what is the APC?

JMIRx Med is a fully open-access journal. APC about USD 1,000.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .